Overview
Central pontine myelinolysis (CPM) is a neurological disorder characterized by the demyelination of nerve fibers in the central part of the pons, often associated with rapid shifts in electrolyte concentrations, particularly sodium. It is typically considered fatal, though rare cases of recovery have been reported 1.Diagnosis
Clinical Presentation: Neurological deficits including pseudobulbar symptoms, movement disorders, and altered consciousness 12.
Imaging: CT or MRI showing characteristic hyperintense lesions in the pons 1.
Electrolyte Abnormalities: Rapid correction of hyponatremia or hypernatremia preceding symptoms 12.
Pathological Features: Not routinely assessed in clinical practice but discussed in case reports 2.Management
Supportive Care: Focus on intensive neurological monitoring and supportive measures including ventilation support if needed 1.
Electrolyte Management: Avoid rapid correction of sodium levels to prevent further demyelination 1.
No Specific Pharmacological Treatment: No evidence-based pharmacological interventions are widely recommended 1.Special Populations
Chronic Alcoholism and Liver Cirrhosis: CPM can occur in patients with chronic alcoholism and liver cirrhosis, as seen in a UK case report 2.Key Recommendations
Monitor and Manage Electrolytes Gradually: Avoid rapid correction of sodium levels to mitigate risk of CPM (Evidence: Moderate 1).
Utilize Imaging for Diagnosis: CT or MRI can confirm CPM diagnosis through characteristic imaging findings (Evidence: Weak 1).
Provide Comprehensive Supportive Care: Intensive neurological monitoring and supportive therapies are crucial (Evidence: Expert opinion 1).References
1 Stam J, van Oers MH, Verbeeten B. Recovery after central pontine myelinolysis. Journal of neurology 1984. link
2 Ibrahim NB. Central pontine myelinolysis. Postgraduate medical journal 1981. link